new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge bioinformatics software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one bioinformatics software provider empowering you from Sample to Insight.
We are excited to share with you news of the new QIAGEN CLC Genomics version 22, which offers you ma...
The industry-leading NGS variant interpretation and reporting software now includes a new Clinical V...
More mutations, better annotations, confident classifications HGMD Professional 2021.4 is now avai...
With the scientific research community publishing over two million peer-reviewed articles every yea...
If you work in cancer biomarker and target research, chances are you use data from The Cancer Genome...
Learn what’s new in the QIAGEN CLC Genomics version 22 (v22) release
New Features Available in QIAGEN Clinical Insight (QCI) Update
New Content Release: HGMD Professional 2021.4
How to accelerate reliable and novel answers with expert-curated biomedical and clinical data
A better way to explore TCGA data
Targeted NGS panels and optimized analysis and interpretation bioinformatics software tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics software and services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients